SENORES PHARMACEUTICALS L - Asset Resilience Ratio

Latest as of September 2025: 21.30%

SENORES PHARMACEUTICALS L (SENORES) has an Asset Resilience Ratio of 21.30% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read SENORES liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

Rs2.74 Billion

≈ $29.67 Million USD Cash + Short-term Investments

Total Assets

Rs12.88 Billion

≈ $139.31 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2022–2024)

This chart shows how SENORES PHARMACEUTICALS L's Asset Resilience Ratio has changed over time. See SENORES PHARMACEUTICALS L shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down SENORES PHARMACEUTICALS L's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SENORES market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs2.74 Billion	21.3%
Total Liquid Assets	Rs2.74 Billion	21.30%

Asset Resilience Insights

Good Liquidity Position: SENORES PHARMACEUTICALS L maintains a healthy 21.30% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

SENORES PHARMACEUTICALS L Industry Peers by Asset Resilience Ratio

Compare SENORES PHARMACEUTICALS L's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
AbbVie Inc NYSE:ABBV	Drug Manufacturers - General	0.02%
Roche Holding AG SW:ROG	Drug Manufacturers - General	15.37%
Biogen Inc NASDAQ:BIIB	Drug Manufacturers - General	2.74%
CSPC Pharmaceutical Group Limited F:CVG	Drug Manufacturers - General	4.64%
AstraZeneca PLC LSE:AZN	Drug Manufacturers - General	0.03%
Yifan Xinfu Pharmaceutical Co Ltd SHE:002019	Drug Manufacturers - General	0.53%
Hubei Guangji Pharmaceutical Co Ltd SHE:000952	Drug Manufacturers - General	5.37%
Dimed S.A. Distribuidora de Medicamentos SA:PNVL3	Drug Manufacturers - General	10.10%

Annual Asset Resilience Ratio for SENORES PHARMACEUTICALS L (2022–2024)

The table below shows the annual Asset Resilience Ratio data for SENORES PHARMACEUTICALS L.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-03-31	0.84%	Rs52.08 Million ≈ $563.23K	Rs6.22 Billion ≈ $67.25 Million	-1.18pp
2022-03-31	2.02%	Rs11.95 Million ≈ $129.23K	Rs591.52 Million ≈ $6.40 Million	--

pp = percentage points

About SENORES PHARMACEUTICALS L

NSE:SENORES India Drug Manufacturers - General

Market Cap

$447.85 Million

Rs41.41 Billion INR

Market Cap Rank

#13131 Global

#617 in India

Share Price

Rs899.20

Change (1 day)

-0.48%

52-Week Range

Rs483.75 - Rs939.75

All Time High

Rs939.75